Rizatriptan Benzoate
Product Images NDC 45865-825

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 45865-825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (825 12)

Label for Rizatriptan Benzoate Tablets 10 mg, generic for Maxalt, in a package of 12 tablets. The label includes dosage strength, tablet description as light pink, oblong, with each tablet containing 10 mg of rizatriptan. The manufacturer is identified as Breckenridge Pharmaceutical, Inc. Additional bilingual warnings about dizziness, drowsiness, and alcohol avoidance are visible, along with instructions to take the medication as directed by a physician.*

FDA Label Image

Figure1 (Figure1)

A Kaplan-Meier plot graph showing the estimated probability of headache response over time within 2 hours post-dose. It compares response rates for placebo, Rizatriptan benzoate 5mg tablets, and Rizatriptan benzoate 10mg tablets, illustrating increasing response probabilities over time among the groups.*

FDA Label Image

Figure2 (Figure2)

A Kaplan-Meier plot showing the estimated probability of headache response over 24 hours post-dose for placebo, Rizatriptan benzoate 5mg tablets, and Rizatriptan benzoate 10mg tablets. The graph compares the effectiveness of the two dosages versus placebo in clinical trials.*

FDA Label Image

Structure (Structure)

Chemical structure of rizatriptan benzoate. The diagram shows the molecular arrangement typical for rizatriptan linked with a benzoate group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.